“Medicinal cannabis derivatives in the treatment of children and adolescents with refractory epilepsy assisted in a reference center in Uruguay between 2021-2024: Usage profile, benefits and risks”, Arch Pediatr Urug, vol. 96, no. 1, p. e203, Jun. 2025, doi: 10.31134/ap.96.3.